Gülay Aşçı

ORCID: 0000-0001-5582-6430
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dialysis and Renal Disease Management
  • Blood Pressure and Hypertension Studies
  • Parathyroid Disorders and Treatments
  • Cardiovascular Health and Disease Prevention
  • Renal Transplantation Outcomes and Treatments
  • Central Venous Catheters and Hemodialysis
  • Renal and Vascular Pathologies
  • Renal Diseases and Glomerulopathies
  • Chronic Kidney Disease and Diabetes
  • Body Composition Measurement Techniques
  • Diabetes Treatment and Management
  • Muscle and Compartmental Disorders
  • Potassium and Related Disorders
  • Pharmacological Effects and Toxicity Studies
  • Hemodynamic Monitoring and Therapy
  • Organ Donation and Transplantation
  • Vitamin D Research Studies
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Hematological disorders and diagnostics
  • Neurological and metabolic disorders
  • Neurological Complications and Syndromes
  • Cardiovascular Function and Risk Factors
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Heart Failure Treatment and Management
  • Organ Transplantation Techniques and Outcomes

Ege University
2014-2024

Ege Üniversitesi Tıp Fakültesi Hastanesi
2024

Turkish Society of Hematology
2023

Pediatric Nephrology of Alabama
2007-2015

University of Turin
2012

Emory University
2011

University Medical Center Utrecht
2011

Okayama University
2007

Amsterdam UMC Location University of Amsterdam
2007

University of Thessaly
2007

Online haemodiafiltration (OL-HDF) is considered to confer clinical benefits over haemodialysis (HD) in terms of solute removal patients undergoing maintenance HD. The aim this study was compare postdilution OL-HDF and high-flux HD morbidity mortality. In prospective, randomized, controlled trial, we enrolled 782 thrice-weekly randomly assigned them a 1:1 ratio either or mean age 56.5 ± 13.9 years, time on 57.9 44.6 months with diabetes incidence 34.7%. follow-up period 2 the 22.7 10.9...

10.1093/ndt/gfs407 article EN Nephrology Dialysis Transplantation 2012-12-09

Most haemodialysis (HD) centres use anti-hypertensive drugs for the management of hypertension, whereas some apply dietary salt restriction strategy. In this retrospective cross-sectional study, we assessed effectiveness and cardiac consequences these two strategies.We enrolled all patients from dialysis centres, who had been on a standard HD programme at same centre least 1 year. All underwent echocardiographic evaluation. Clinical data were obtained patients' charts. Centre A (n = 190)...

10.1093/ndt/gfn599 article EN Nephrology Dialysis Transplantation 2008-10-08

We analysed the survival of 218 patients (132 male, 86 female, age 48 +/- 15 years) who were treated in our dialysis units since we adopted strategy strict volume control without antihypertensive drugs. The mean observation period was 47 34 (6-140) months. Follow-up ended because death (57 patients), transfer to another center (35 continous ambulatory peritoneal (CAPD) (15 patients) or transplantation (23 while 88 still under treatment at time writing.Blood pressure (BP) decreased from a 150...

10.1093/ndt/gfl487 article EN Nephrology Dialysis Transplantation 2006-09-23

Background.Vascular calcification (VC), mainly due to elevated phosphate levels, is one major problem in patients suffering from chronic kidney disease.In clinical studies, an inverse relationship between serum magnesium and VC has been reported.However, there only few information about the influence of on a cellular level available.Therefore, we investigated effect induced by b-glycerophosphate (BGP) bovine vascular smooth muscle cells (BVSMCs).Methods.BVSMCs were incubated with media for...

10.1093/ndt/gfr321 article EN cc-by-nc Nephrology Dialysis Transplantation 2011-07-12

Background. Longer dialysis sessions may improve outcome in haemodialysis (HD) patients. We compared the clinical and laboratory outcomes of 8- 4-h thrice-weekly HD.

10.1093/ndt/gfq724 article EN Nephrology Dialysis Transplantation 2010-12-09

Exposure to high Ca concentrations may influence the development of low–turnover bone disease and coronary artery calcification (CAC) in patients on hemodialysis (HD). In this randomized, controlled study, we investigated effects lowering dialysate level progression CAC histologic abnormalities HD. Patients HD with intact parathyroid hormone levels ≤300 pg/ml receiving containing 1.75 or 1.50 mmol/L ( n =425) were randomized 1.25-mmol/L (1.25 Ca; =212) 1.75-mmol/L (1.75 =213) arm. Primary...

10.1681/asn.2015030268 article EN Journal of the American Society of Nephrology 2015-12-23

Low serum testosterone levels in hemodialysis (HD) patients have recently been associated with cardiovascular risk factors and increased mortality. To confirm this observation, we investigated the predictive role of total on mortality a large group male HD from Turkey.A 420 prevalent were sampled March 2005 followed up for all-cause Serum measured by ELISA at baseline studied relation to profile.Mean level was 8.69 ± 4.10 (0.17 27.40) nmol/L. A proportion (66%) had deficiency (<10 nmol/L)....

10.2215/cjn.03600410 article EN Clinical Journal of the American Society of Nephrology 2010-07-23

Background. Vascular calcifications are frequent in Stage 5 chronic kidney disease (CKD-5) patients receiving haemodialysis. The current study was designed to evaluate the associations between bone turnover/volume and coronary artery (CAC). Methods. In 207 CKD-5 patients, biopsies, multislice computed tomography of arteries blood drawings for relevant biochemical parameters were done. large number enrolled allowed separate evaluation with CAC versus without adjustment traditional...

10.1093/ndt/gfq491 article EN Nephrology Dialysis Transplantation 2010-08-13

Background and objectives End-stage renal disease is linked to alterations in thyroid hormone levels and/or metabolism, resulting a high prevalence of subclinical hypothyroidism low triiodothyronine (T3) levels. These are involved endothelial damage, cardiac abnormalities, inflammation, but the exact mechanisms unclear. In this study, we investigated relationship between serum free-T3 (fT3) carotid artery atherosclerosis, arterial stiffness, vascular calcification prevalent patients on...

10.2215/cjn.02540311 article EN Clinical Journal of the American Society of Nephrology 2011-08-12

Objective Peritoneal fibrosis (PF) is one of the most serious causes failure in continuous ambulatory peritoneal dialysis (PD). Although underlying mechanism responsible for genesis PF still unknown, transforming growth factor p (TGFβ 1 ) has been shown to be associated with PF. Angiotensin converting enzyme inhibitors have prevent stimulating effect factors. The aim present study was investigate enalapril on function and morphology a rat model experimental Methods Twenty-one albino Wistar...

10.1177/089686080102100221 article EN Peritoneal Dialysis International 2001-03-01

&lt;i&gt;Background:&lt;/i&gt; Serum free triiodothyronine (fT3) level is suggested to be a risk factor for mortality in unselected dialysis patients. We investigated the prognostic value of serum fT3 levels and also low-T3 syndrome on overall survival large cohort hemodialysis (HD) patients with normal thyroid-stimulating hormone levels. &lt;i&gt;Methods:&lt;/i&gt; A total 669 prevalent HD were enrolled study. was measured by enzyme immune assay frozen sera samples at time enrollment....

10.1159/000324883 article EN American Journal of Nephrology 2011-01-01

Objective: The purpose of this study was to investigate the association neutrophil/lymphocyte ratio and platelet/lymphocyte with clinical outcomes in geriatric patients stage 3–5 chronic kidney disease (CKD).Material Methods: A total 165 over age 65, CKD, were enrolled study. primary endpoints all-cause deaths requirement renal replacement therapy. divided into two groups according delta such as increased (group 1) decreased or stable 2) groups.Results: mean 73.8 ± 6.1 years follow-up 30 13...

10.1080/17843286.2016.1159797 article EN Acta Clinica Belgica 2016-05-20

Presence of accelerated atherosclerosis in dialysis patients cannot be entirely explained by conventional risk factors. Exposure to urea, which is elevated with kidney disease, leads the carbamylation proteins. We investigated effects carbamylated low-density lipoprotein (cLDL) on human coronary artery vascular smooth muscle cells (VSMC).Native LDL (nLDL) was potassium cyanate. Cells were incubated different concentrations cLDL at time points. Cytotoxicity, apoptosis, proliferation...

10.1111/j.1440-1797.2008.00948.x article EN Nephrology 2008-06-02

Demirci MS, Toz H, Yılmaz F, Ertilav M, Asci G, Ozkahya Zeytinoglu A, Nart D, Ok E. Risk factors and consequences of post‐transplant diabetes mellitus. Clin Transplant 2010 DOI: 10.1111/j.1399‐0012.2010.01247.x. © John Wiley &amp; Sons A/S. Abstract: Background: The aim this study is to investigate the clinical course as well risk prognosis mellitus (PTDM). Methods: Five hundred fifty‐five kidney transplant recipients were retrospectively evaluated. PTDM was defined fasting blood glucose...

10.1111/j.1399-0012.2010.01247.x article EN Clinical Transplantation 2010-04-05

The effects of high-flux dialysis and ultrapure dialysate on survival hemodialysis patients are incompletely understood. We conducted a randomized controlled trial to investigate the both membrane permeability purity cardiovascular outcomes. randomly assigned 704 three times per week either high- or low-flux dialyzers standard using two-by-two factorial design. primary outcome was composite fatal nonfatal events during minimum 3 years follow-up. did not detect statistically significant...

10.1681/asn.2012090908 article EN Journal of the American Society of Nephrology 2013-04-26
Coming Soon ...